126 related articles for article (PubMed ID: 12374652)
1. Breast cancer and leukemia: the forest for the trees?
Hudis C
Ann Surg Oncol; 2002 Oct; 9(8):717-8. PubMed ID: 12374652
[No Abstract] [Full Text] [Related]
2. Side effects of adjuvant treatment of breast cancer.
Shapiro CL; Recht A
N Engl J Med; 2001 Jun; 344(26):1997-2008. PubMed ID: 11430330
[No Abstract] [Full Text] [Related]
3. Increase therapy-related leukemia secondary to breast cancer.
Carli PM; Sgro C; Parchin-Geneste N; Isambert N; Mugneret F; Girodon F; Maynadié M
Leukemia; 2000 Jun; 14(6):1014-7. PubMed ID: 10865966
[TBL] [Abstract][Full Text] [Related]
4. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
5. Secondary leukemia after autologous peripheral blood progenitor cell transplantation for breast cancer.
Sica S; Salutari P; Ciarli M; Piccirillo N; Laurenti L; Menichella G; Leone G
Leukemia; 1997 Nov; 11(11):1990-2. PubMed ID: 9369440
[No Abstract] [Full Text] [Related]
6. Leukemia after chemotherapy for cancer.
Chasen MR; Falkson G
Cancer Biother; 1993; 8(2):115-22. PubMed ID: 7804352
[No Abstract] [Full Text] [Related]
7. Leukemogenic effect of chemotherapy in patients with breast carcinoma: is it a real concern?
Ibrahim NK
Cancer; 2004 Oct; 101(7):1479-81. PubMed ID: 15378475
[No Abstract] [Full Text] [Related]
8. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
[TBL] [Abstract][Full Text] [Related]
9. How breast cancer chemotherapy increases the risk of leukemia: Thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy.
Zhang B; Zhang X; Li M; Kong L; Deng X; Yu J
Cancer Biol Ther; 2016; 17(2):125-8. PubMed ID: 26861804
[TBL] [Abstract][Full Text] [Related]
10. [Pancytopenia and macular rash in a woman with a history of breast cancer].
Jacobi D; Vidal C; Gironet N; Machet MC; Machet L
Rev Med Interne; 2003 Jun; 24(6):399-400. PubMed ID: 12814830
[No Abstract] [Full Text] [Related]
11. Lineage-specific hematopoietic growth factors.
Ferretti G; Papaldo P; Cognetti F
N Engl J Med; 2006 Aug; 355(5):526; author reply 527. PubMed ID: 16885561
[No Abstract] [Full Text] [Related]
12. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study.
Chaplain G; Milan C; Sgro C; Carli PM; Bonithon-Kopp C
J Clin Oncol; 2000 Aug; 18(15):2836-42. PubMed ID: 10920131
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines.
Ando M; Narabayashi M; Watanabe T; Kamiya Y; Togitani K; Tanosaki R; Takenaka T; Tobinai K; Adachi I
Jpn J Clin Oncol; 1999 Jan; 29(1):28-32. PubMed ID: 10073148
[TBL] [Abstract][Full Text] [Related]
14. An unusual case of chronic lymphocytic leukemia following primary breast carcinoma on chemotherapy.
Chandra H; Chandra S; Verma SK; Pathak VP
J Postgrad Med; 2011; 57(1):55-6. PubMed ID: 21206118
[No Abstract] [Full Text] [Related]
15. Long-term effects of adjuvant chemotherapy in breast cancer.
Forbes JF
Acta Oncol; 1992; 31(2):243-50. PubMed ID: 1622641
[TBL] [Abstract][Full Text] [Related]
16. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
Wei JL; Jiang YZ; Shao ZM
Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta C; Casagranda I; Semino G; Moroni M; Ratto C
Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
[No Abstract] [Full Text] [Related]
18. Secondary hematological malignancies after breast cancer chemotherapy.
Park MJ; Park YH; Ahn HJ; Choi W; Paik KH; Kim JM; Chang YH; Ryoo BY; Yang SH
Leuk Lymphoma; 2005 Aug; 46(8):1183-8. PubMed ID: 16085560
[TBL] [Abstract][Full Text] [Related]
19. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
Atkins CD
J Natl Cancer Inst; 1996 Oct; 88(20):1496-7; author reply, 1497-9. PubMed ID: 8841029
[No Abstract] [Full Text] [Related]
20. Secondary malignancies following cancer chemotherapy.
Boffetta P; Kaldor JM
Acta Oncol; 1994; 33(6):591-8. PubMed ID: 7946433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
